Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Cannabis is a Brazil-based digital health and education company focused on the legal medical cannabis market. The company built a platform that educates healthcare professionals, informs patients, and connects patients with physicians and other participants involved in cannabinoid-based care. Its commercial offering has included online courses for prescribers and practitioners, patient-facing content, and marketplace-style services intended to simplify access to legal medical cannabis treatment in Brazil. The business was founded in 2017 and launched publicly in 2018, and in 2022 it was combined with Cannect in a merger that was described as creating a leading medical cannabis marketplace in Latin America. Dr. Cannabis remains an identifiable brand and legal entity with an active Brazilian corporate registration and an operating web presence centered on education and access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Cannabis.